RE: Stockepedia26 Jun 2023 08:45
interesting post gp. i have followed creo for more than a decade and i have no doubts at all about the product and the technology. chris han**** is genuinely a genius. the trouble has been that you cannot just put the product on a shop shelf, you have to get consultants on board literally one at a time and offer training as part of the sales package. this is very labour intensive and time consuming. which is also why so much interest is being shown in the relationship with intuitive, where bulk sales could be made and the training problem largely falls away. i think the company made mistakes, it’s headcount is way too high, the acquisitions have been a distraction not an asset. there have been some governance issues too. a non executive director was recruited, placed almost immediately on the directors’ remuneration committee and within six months approved massive cash bonuses for two directors, ostensibly on the grounds that the acquisitions had been such a success and despite the onset of the pandemic. pretty daft in my mind, plus any bonus should have been in shares not cash, with the cash reserved exclusively for its original purposes, product development and working capital. so there have been some bumps in the road, covid very unfortunate when you need access to consultants and hospitals, excessive recruitment (imo) and until recently no sign of a clear sales strategy. having said all that i remain very confident they will prevail and recover the lost ground.